Lung Cancer
Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma: Prescribing Data Direct from High-Prescribing US Oncologists
Published in Cancer Weekly, May 24th, 2011
A patient specific case scenario on advanced lung cancer in a situation involving a patient with EGFR Mutation Positive Adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient Progression Reveals: Decisions in treatment and tests through disease stages
Factors influencing their decisions
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-05-24)
More Articles from Cancer Weekly
- Prostate Cancer
Advanced Prostate Cancer with Increased PSA and Adenocarcinoma: Clinical Insights from a US Oncologists' Survey - Skin Cancer
Banana Boat(R) Sun Care Sets Out To Raise $101,000 for The Skin Cancer Foundation by "Sun Certifying" 101,000 Americans - Colon Cancer
Data on Colon Cancer Detailed by Researchers at NanJing University - Lung Cancer
Data on Lung Cancer Detailed by Researchers at National Heart and Lung Institute - Health Care, Hospitals
Lance Armstrong in Calgary to Support The Canadian Breast Cancer Foundation -prairies/nwt Region - Pancreatic Cancer
Mayo Clinic Reports New Findings on Noninvasive Test for Pancreatic Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
